SAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) approved ...
Despite being the most common vaginal condition,1 BV symptoms are often mistaken for a yeast infection2 JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a ...
Credit: Getty Images. Xaciato, a lincosamide antibacterial, is a thermosetting bioadhesive hydrogel containing clindamycin phosphate 2%. The Food and Drug Administration (FDA) has approved Xaciato™ ...
FT. WORTH, Texas--(BUSINESS WIRE)--One of the most widely prescribed drugs for acne vulgaris is benzoyl peroxide (BPO). However, at concentrations of 5-10%, BPO has the potential for skin irritation ...
Clindamycin (as phosphate) 1%. Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is predominantly bacteriostatic. Although ...
December 1, 2006 — The US Food and Drug Administration (FDA) has approved clindamycin phosphate/tretinoin 1.2%/0.025% gel for the once-daily topical treatment of acne vulgaris in patients aged 12 ...
Clindamycin is an antibiotic doctors prescribe to treat tooth infections, particularly if you’re allergic to penicillin. It’s safe for most people but may cause digestive side effects, and should ...
Study results suggest the greatest risk for Clostridioides difficile infection was observed with use of clindamycin while the lowest risk was observed with doxycycline and minocycline. Results of the ...
Latest market research report on Global Clindamycin phosphate Topical Market published by Global Market Monitor, offers updated COVID-19 Impacts on global or regional Clindamycin phosphate Topical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results